Drug Launch
Search documents
Insmed(INSM) - 2025 Q4 - Earnings Call Transcript
2026-02-19 14:02
Insmed (NasdaqGS:INSM) Q4 2025 Earnings call February 19, 2026 08:00 AM ET Company ParticipantsBryan Dunn - Head of Investor RelationsGraig Suvannavejh - Managing DirectorJason Zemansky - VPMartina Flammer - CMOSara Bonstein - CFOSteven Willey - Managing DirectorWill Lewis - Chair and CEOConference Call ParticipantsAdam Walsh - Managing Director and Senior Biotechnology Equity Research AnalystGavin Clark-Gartner - Managing Director and Biotechnology Equity Research AnalystJessica Fye - Managing Director and ...
Insmed(INSM) - 2025 Q4 - Earnings Call Transcript
2026-02-19 14:00
Insmed (NasdaqGS:INSM) Q4 2025 Earnings call February 19, 2026 08:00 AM ET Speaker17Thank you for standing by, and welcome to the Insmed fourth quarter and full year 2025 financial results conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your ques ...